Quantcast
 
Read Larry Connors' blogShort Term Trading Strategies


BSX

BRIEF: $12,000 grant funds 250 Thanksgiving food boxes: Boston Scientific Foundation, Spencer Presbyterian Food Pantry team up to help needy - 11/21 - 04:12 PM ET

Boston Scientific to close Doral plant: Even as Miami-Dade officials try to build the county's life sciences industry, Boston Scientific is planning to close a plant in Doral and send the jobs overseas. - 11/21 - 06:36 AM ET

Boston Scientific to close plant, send 1,400 jobs to Costa Rica - 11/20 - 06:53 PM ET

Boston Scientific to close Doral plant, eliminate 1,400 jobs - 11/20 - 05:24 PM ET

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent - 11/20 - 08:30 AM ET

Boston Scientific Down 17.7% Since SmarTrend's Sell Recommendation - 11/17 - 12:17 PM ET

Watchdog: He's working, but in 'permanent job transition': Pioneer Press job panelist says constant job search is today's reality - 11/16 - 08:10 PM ET

BRIEF: Pain relief device to be on display in Sartell - 11/12 - 04:18 AM ET

Boston Scientific launches two new cardiovascular devices in Japan - 11/11 - 09:51 AM ET

Boston Scientific Down 17.8% Since SmarTrend's Sell Recommendation - 11/10 - 10:36 AM ET

Boston Scientific Announces Sponsorship of World Diabetes Day Campaign 2009 - 11/10 - 08:30 AM ET

Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress - 11/09 - 05:01 PM ET

Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan - 11/09 - 08:30 AM ET

Boston Scientific Settles DOJ Guidant Probe For $296 Mln.; Takes Q3 Charge, Lowers FY09 GAAP EPS View - Update - 11/06 - 11:58 AM ET

Boston Scientific Paying $296 Million To Settle Investigation Into Guidant Unit (BSX) - 11/06 - 10:47 AM ET

Boston Scientific (BSX) Bearish Technical Alert - Trend Down 21.2% - 11/03 - 03:29 PM ET

Boston Scientific gets OK for stent in Europe: Promus Element is a higher-profit item - 11/03 - 03:34 AM ET

Boston Scientific gets OK to sell stent in Europe - 11/02 - 12:08 PM ET

Video: Boston Scientific Announces European Approval and Launch of Platinum Chromium PROMUS(R) Element(TM) Stent System - 11/02 - 08:45 AM ET

Boston Scientific (BSX) Bearish Technical Alert - Trend Down 14.7% - 10/26 - 02:34 PM ET

Page 1 of 11     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index

 

Most Popular News
  UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.